Daniel E. Soffer
Daniel E. Soffer publishes mostly in Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine, on topics such as Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins and Lipid metabolism and disorders.
- World rank
- #1,072,338 of 7,710,434 ranked researchers
- Rank in United States
- #347,844 of 1,627,098
- Works
- 98
- Citations
- 2k
- Citations per work
- 20.0
What does Daniel E. Soffer research?
Daniel E. Soffer's work is mostly in Medicine (59%), Biochemistry, Genetics and Molecular Biology (6%), Economics, Econometrics and Finance (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5859.4%
- Medicine5859.4%
- Everything else2929.1%
- Life Sciences66.4%
- Social Sciences55.1%
- 1Surgery27% of their works
- 2Endocrinology, Diabetes and Metabolism16% of their works
- 3Cardiology and Cardiovascular Medicine12% of their works
- 4Cancer Research6% of their works
- 5Economics and Econometrics5% of their works
- 6Epidemiology5% of their works
Research topics
- Lipoproteins and Cardiovascular Health
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Lipid metabolism and disorders
- Cancer, Lipids, and Metabolism
- Health Systems, Economic Evaluations, Quality of Life
- Liver Disease Diagnosis and Treatment
- Pancreatitis Pathology and Treatment
- Pharmaceutical Economics and Policy
Which keywords describe Daniel E. Soffer's research?
The keywords of their largest research topics: Statins, Cardiovascular Disease Prevention, Cholesterol-lowering, Metabolic Syndrome, Atherosclerosis, Cholesterol, Insulin Resistance and Cardiovascular Disease.
- NAFLD
- Drug Development Costs
- Acute Pancreatitis
- Cost-effectiveness Analysis
- Fatty Acid Synthase
- ANGPTL3
- Cardiovascular Disease
- Cholesterol
- Metabolic Syndrome
- Cardiovascular Disease Prevention
- Statins
- Cholesterol-lowering
- Atherosclerosis
- Insulin Resistance
- Diabetes
- Lipoprotein Lipase
- Lipid Metabolism
- Quality of Life
- Chronic Pancreatitis
- Generic Drugs
- NASH
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Statins662 topics
- Cardiovascular Disease Prevention521 topic
- Cholesterol-lowering521 topic
- Metabolic Syndrome523 topics
- Atherosclerosis472 topics
- Cholesterol462 topics
- Insulin Resistance372 topics
- Cardiovascular Disease321 topic
- Diabetes321 topic
- ANGPTL3151 topic
- Lipoprotein Lipase151 topic
- Fatty Acid Synthase141 topic
- Lipid Metabolism141 topic
- Cost-effectiveness Analysis71 topic
- Quality of Life71 topic
- Acute Pancreatitis51 topic
- Chronic Pancreatitis51 topic
- Drug Development Costs51 topic
- Generic Drugs51 topic
- NAFLD51 topic
- NASH51 topic
Where does Daniel E. Soffer work?
Daniel E. Soffer's main affiliation in the publication record is University of Pennsylvania, United States.
How many publications and citations does Daniel E. Soffer have?
OpenAlex counts 98 works and 1,961 citations for Daniel E. Soffer, an h-index of 18, ranking #1,072,338 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Daniel E. Soffer
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Daniel E. Soffer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.